Searched for
GLAND PHARMA SHARE PRICE
Mid-cap stocks: Time for a change of stance? 6 mid-caps from different sectors with an upside potential up to 29%Sometimes the real market story is not in the headline index. The Nifty and Sensex can be under pressure, and yet, below them, mid- and sma...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 23%Market breadth (always a better indicator of the underlying sentiment) has remained positive for a few trading sessions in a row. This is w...
- Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Defence stocks: Time to change strategy? 18 stocks with downside and upside potential from minus 26% to plus 26%When a stock remains in the red for several months, investors naturally begin questioning the investment. Imagine a shipbuilder remaining w...
- Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...
- Q1 Results Tracker: Tata Motors, Vodafone Idea among 2,045 companies set to announce earnings this weekGoldman Sachs expects the Nifty 50 to rebound to 26,500 by June 2027, above its current record high, as India’s macro backdrop improves. Lo...
- Dividend alert: Jio Financial, Power Grid, HPCL among 90 stocks turning ex-dividend this weekNearly 90 companies, including Jio Financial Services, Power Grid Corporation, HPCL, and Hindustan Aeronautics, will turn ex-dividend betwe...
- Man with a bleeding forehead gets rushed to the hospital. He has no cuts or scratches. Doctor explains what made him bleed: ‘An adrenaline spike can cause…'An internal medicine expert recently shared an anecdote about a patient who started bleeding from the forehead without any wounds or scratc...
- These large and mid-cap stocks can give more than 20% return in 1 year, according to analystsWhenever there is a correction or volatility, just ask one question: Is it an opportunity, or should one be wary? We are raising this issue...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsA word of caution for all those who have exposure to mid cap stocks or are planning to increase it. Just keep one thing in mind: If there i...
- Dr Reddy's Laboratories launches generic Sugammadex injection in the United StatesDr Reddy's Laboratories has launched its generic Sugammadex injection in the United States. This new product reverses muscle relaxant effec...
- Market wrap: TCS, IndiGo, Sun Pharma among top gainers and losers on Nifty and Sensex on MondayIndian benchmark indices surged on Monday after easing crude oil prices, sparked by renewed US-Iran talks, boosted investor sentiment. The ...
- In 2007, scientists found snakes on Japan's Ishima island didn't just eat toxic toads, they borrowed their toxins for defenseSnakes use toad toxins: Researchers discovered Asian snakes sequester toxins from toxic toads for defense. These snakes store borrowed toxi...
- Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...
- PCBL Chemical among 4 stocks closing above VWAP, signalling bullish shiftFour Nifty500 stocks, including PCBL Chemical, Blue Jet Healthcare, Gland Pharma, and International Gemological Institute, closed above the...
- Gland Pharma gets USFDA nod for generic sugammadex injectionGland Pharma secured USFDA approval for its sugammadex injection generic version. This drug reverses muscle relaxant effects used during su...
- Tariff on generic drugs: Loud announcement, little consequence? 7 pharma stocks with upside potential of up to 31%The threat of a US tariff on Indian pharma is no longer a vague fear; or at least that is what President Trump wants us to believe. There i...
Load More
